NCT01012557View on ClinicalTrials.gov

H1N1v Vaccination of Pregnant Women: A Longitudinal Cohort Study Characterizing Influenza A H1N1v Vaccination in Pregnant Women

NACompletedINTERVENTIONAL
Enrollment

296

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

September 30, 2010

Study Completion Date

December 31, 2011

Conditions
H1N1v Influenza
Interventions
BIOLOGICAL

Focetria

7.5 mcg H1N1v full MF59 adjuvant i.m.(intramuscular)x 1

BIOLOGICAL

Focetria

3.75 mcg H1N1v half MF59 adjuvant i.m.(intramuscular)x 1

BIOLOGICAL

Focetria

15 mcg N1N1v unadjuvanted i.m.(intramuscular) x 1.

BIOLOGICAL

Focetria

7.5 mcg H1N1v full MF59 adjuvant i.m.(intramuscular) x 1

Trial Locations (2)

2620

COPSAC, Gentofte Municipality

4700

Næstved Hospital, Pediatric Department, Næstved

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Copenhagen Studies on Asthma in Childhood

OTHER